Clinical endocrinology · 2026
Bardet-Biedl Syndrome in India: Genotypic Spectrum and Clinical Features From a Single-Centre Cohort.
СтатьяНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Thiriveedi Deepak, Goroshi Manjunath, Ganakumar Vanishri, Ghatnatti Vikrant
Аннотация
BACKGROUND: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive ciliopathy with multisystem involvement. While BBS1 mutations are common globally, population-specific genetic patterns and phenotype severity vary. This study aimed to investigate genotype-phenotype correlations in an Indian cohort.
METHODS: In this single-centre, observational cohort study, individuals meeting Beales' clinical criteria for BBS underwent next-generation sequencing (NGS). Phenotypic features were correlated with underlying genotypes, with particular attention to the type of mutation (truncating vs. non-truncating) and the implicated gene subgroup (chaperonin-like vs. BBSome complex).
RESULTS: Of 15 patients screened, nine were confirmed to have BBS. The most frequently mutated genes were BBS10 and BBS2 (33.3% each), followed by BBS9 and BBS12. All variants were homozygous, with truncating mutations observed in 77.8% of cases. Obesity was universally present, while retinal dystrophy and polydactyly were each seen in 88.9% of patients. Renal abnormalities were less frequent (22.2%) and were observed only among patients with truncating variants in this cohort. Compared with non-truncating mutations, truncating variants were associated with earlier diagnosis (median age: 14 vs. 28.5 years), possibly reflecting earlier clinical manifestations. Notably, earlier onset of disease and broader multisystem involvement were more frequently observed in patients with BBS10 mutations.
CONCLUSION: This study provides descriptive insights into the genotypic spectrum of BBS in an Indian cohort, with frequent involvement of BBS10 and BBS2. The findings underscore the importance of population-specific genetic data and highlight the potential value of early genetic evaluation in consanguineous families.
METHODS: In this single-centre, observational cohort study, individuals meeting Beales' clinical criteria for BBS underwent next-generation sequencing (NGS). Phenotypic features were correlated with underlying genotypes, with particular attention to the type of mutation (truncating vs. non-truncating) and the implicated gene subgroup (chaperonin-like vs. BBSome complex).
RESULTS: Of 15 patients screened, nine were confirmed to have BBS. The most frequently mutated genes were BBS10 and BBS2 (33.3% each), followed by BBS9 and BBS12. All variants were homozygous, with truncating mutations observed in 77.8% of cases. Obesity was universally present, while retinal dystrophy and polydactyly were each seen in 88.9% of patients. Renal abnormalities were less frequent (22.2%) and were observed only among patients with truncating variants in this cohort. Compared with non-truncating mutations, truncating variants were associated with earlier diagnosis (median age: 14 vs. 28.5 years), possibly reflecting earlier clinical manifestations. Notably, earlier onset of disease and broader multisystem involvement were more frequently observed in patients with BBS10 mutations.
CONCLUSION: This study provides descriptive insights into the genotypic spectrum of BBS in an Indian cohort, with frequent involvement of BBS10 and BBS2. The findings underscore the importance of population-specific genetic data and highlight the potential value of early genetic evaluation in consanguineous families.